• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

抑制可溶性环氧化物水解酶可减轻博舒替尼引起的血压升高。

Inhibition of Soluble Epoxide Hydrolase Attenuates Bosutinib-Induced Blood Pressure Elevation.

机构信息

Tianjin Key Laboratory of Metabolic Diseases, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Collaborative Innovation Center of Tianjin for Medical Epigenetics, Department of Physiology and Pathophysiology, Tianjin Medical University, China.

出版信息

Hypertension. 2021 Nov;78(5):1527-1540. doi: 10.1161/HYPERTENSIONAHA.121.17548. Epub 2021 Oct 4.

DOI:10.1161/HYPERTENSIONAHA.121.17548
PMID:34601968
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8516812/
Abstract

[Figure: see text].

摘要

[图：见正文]。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ada5/8516812/d1bbf8b77441/hyp-78-1527-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ada5/8516812/54b942929adf/hyp-78-1527-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ada5/8516812/a688957c8f00/hyp-78-1527-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ada5/8516812/2dae6c56a8b4/hyp-78-1527-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ada5/8516812/4ffaaf977376/hyp-78-1527-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ada5/8516812/340ec7616382/hyp-78-1527-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ada5/8516812/d1bbf8b77441/hyp-78-1527-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ada5/8516812/54b942929adf/hyp-78-1527-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ada5/8516812/a688957c8f00/hyp-78-1527-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ada5/8516812/2dae6c56a8b4/hyp-78-1527-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ada5/8516812/4ffaaf977376/hyp-78-1527-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ada5/8516812/340ec7616382/hyp-78-1527-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ada5/8516812/d1bbf8b77441/hyp-78-1527-g006.jpg

相似文献

1
Inhibition of Soluble Epoxide Hydrolase Attenuates Bosutinib-Induced Blood Pressure Elevation.抑制可溶性环氧化物水解酶可减轻博舒替尼引起的血压升高。
Hypertension. 2021 Nov;78(5):1527-1540. doi: 10.1161/HYPERTENSIONAHA.121.17548. Epub 2021 Oct 4.
2
Soluble epoxide hydrolase-dependent regulation of myogenic response and blood pressure.可溶性环氧化物水解酶依赖性调节肌生成反应和血压。
Am J Physiol Heart Circ Physiol. 2014 Apr 15;306(8):H1146-53. doi: 10.1152/ajpheart.00920.2013. Epub 2014 Feb 21.
3
Inhibition of soluble epoxide hydrolase limits niacin-induced vasodilation in mice.抑制可溶性环氧化物水解酶可限制烟酸诱导的小鼠血管舒张。
J Cardiovasc Pharmacol. 2012 Jul;60(1):70-5. doi: 10.1097/FJC.0b013e3182580a5d.
4
Simultaneous inhibition of c-Abl and Src kinases abrogates the exaggerated expression of profibrotic genes in cultured systemic sclerosis dermal fibroblasts.同时抑制 c-Abl 和Src 激酶可消除培养的系统性硬皮病皮肤成纤维细胞中纤维生成基因的过度表达。
Clin Exp Rheumatol. 2018 Jul-Aug;36 Suppl 113(4):36-44. Epub 2018 Sep 7.
5
Novel Src/Abl tyrosine kinase inhibitor bosutinib suppresses neuroblastoma growth via inhibiting Src/Abl signaling.新型Src/Abl酪氨酸激酶抑制剂博舒替尼通过抑制Src/Abl信号传导来抑制神经母细胞瘤的生长。
Oncotarget. 2017 Jan 3;8(1):1469-1480. doi: 10.18632/oncotarget.13643.
6
Soluble Epoxide Hydrolase Inhibition Attenuates MPTP-Induced Neurotoxicity in the Nigrostriatal Dopaminergic System: Involvement of α-Synuclein Aggregation and ER Stress.可溶性环氧化物水解酶抑制减轻 MPTP 诱导的黑质纹状体多巴胺能系统神经毒性：涉及α-突触核蛋白聚集和内质网应激。
Mol Neurobiol. 2018 Jan;55(1):138-144. doi: 10.1007/s12035-017-0726-9.
7
Abrogation of transforming growth factor-β-induced tissue fibrosis in TBRIcaCol1a2Cre transgenic mice by the second generation tyrosine kinase inhibitor SKI-606 (Bosutinib).第二代酪氨酸激酶抑制剂 SKI-606（波舒替尼）抑制 TBRIcaCol1a2Cre 转基因小鼠转化生长因子-β诱导的组织纤维化。
PLoS One. 2018 May 2;13(5):e0196559. doi: 10.1371/journal.pone.0196559. eCollection 2018.
8
Second-generation Src/Abl inhibitor bosutinib effectively induces apoptosis in human esophageal squamous cell carcinoma (ESCC) cells via inhibiting Src/Abl signaling.二代Src/Abl 抑制剂博舒替尼通过抑制Src/Abl 信号通路有效地诱导人食管鳞癌细胞（ESCC）凋亡。
Neoplasma. 2020 Jan;67(1):54-60. doi: 10.4149/neo_2019_190131N94. Epub 2019 Nov 26.
9
Global target profile of the kinase inhibitor bosutinib in primary chronic myeloid leukemia cells.激酶抑制剂博舒替尼在原发性慢性髓性白血病细胞中的全球靶点概况。
Leukemia. 2009 Mar;23(3):477-85. doi: 10.1038/leu.2008.334. Epub 2008 Nov 27.
10
Pharmacological inhibition of soluble epoxide hydrolase or genetic deletion reduces diclofenac-induced gastric ulcers.可溶性环氧化物水解酶的药理学抑制或基因缺失可减少双氯芬酸诱导的胃溃疡。
Life Sci. 2017 Jul 1;180:114-122. doi: 10.1016/j.lfs.2017.05.018. Epub 2017 May 15.

引用本文的文献

1
CEMIP Maintains Vascular Contractility by Controlling PP1c-MLC20 Cascade in SMCs.CEMIP通过控制平滑肌细胞中的PP1c-MLC20级联反应维持血管收缩性。
Circ Res. 2025 Aug;137(4):519-532. doi: 10.1161/CIRCRESAHA.125.326233. Epub 2025 Jul 1.
2
Current Progress on the Influence Human Genetics Has on the Efficacy of Tyrosine Kinase Inhibitors Used to Treat Chronic Myeloid Leukemia.人类遗传学对用于治疗慢性髓性白血病的酪氨酸激酶抑制剂疗效影响的研究进展
Cureus. 2024 Mar 20;16(3):e56545. doi: 10.7759/cureus.56545. eCollection 2024 Mar.
3
Soluble epoxide hydrolase deficiency attenuates airway inflammation in COPD via IRE1α/JNK/AP-1 signaling pathway.

本文引用的文献

1
Tyrosine kinase inhibitor associated vascular toxicity in chronic myeloid leukemia.酪氨酸激酶抑制剂相关的慢性髓性白血病血管毒性
Cardiooncology. 2015 Dec 4;1(1):5. doi: 10.1186/s40959-015-0008-5.
2
Tyrosine kinase inhibitors for solid tumors in the past 20 years (2001-2020).过去 20 年（2001-2020 年）用于实体瘤的酪氨酸激酶抑制剂。
J Hematol Oncol. 2020 Oct 27;13(1):143. doi: 10.1186/s13045-020-00977-0.
3
Suppression of inflammation and fibrosis using soluble epoxide hydrolase inhibitors enhances cardiac stem cell-based therapy.
可溶性环氧化物水解酶缺乏通过IRE1α/JNK/AP-1信号通路减轻慢性阻塞性肺疾病中的气道炎症。
J Inflamm (Lond). 2023 Nov 1;20(1):36. doi: 10.1186/s12950-023-00361-y.
4
Lipidome modulation by dietary omega-3 polyunsaturated fatty acid supplementation or selective soluble epoxide hydrolase inhibition suppresses rough LPS-accelerated glomerulonephritis in lupus-prone mice.膳食ω-3 多不饱和脂肪酸补充或选择性可溶性环氧化物水解酶抑制调节脂类组抑制狼疮易感小鼠粗糙 LPS 加速性肾小球肾炎。
Front Immunol. 2023 Feb 16;14:1124910. doi: 10.3389/fimmu.2023.1124910. eCollection 2023.
使用可溶性环氧化物水解酶抑制剂抑制炎症和纤维化可增强基于心脏干细胞的治疗。
Stem Cells Transl Med. 2020 Dec;9(12):1570-1584. doi: 10.1002/sctm.20-0143. Epub 2020 Aug 13.
4
Association of plasma cyclooxygenase-2 levels and genetic polymorphisms with salt sensitivity, blood pressure changes and hypertension incidence in Chinese adults.血浆环氧化酶-2 水平与基因多态性与中国成年人盐敏感性、血压变化和高血压发病的关系。
J Hypertens. 2020 Sep;38(9):1745-1754. doi: 10.1097/HJH.0000000000002473.
5
Cytochrome P450 epoxygenase-derived 5,6-epoxyeicosatrienoic acid relaxes pulmonary arteries in normoxia but promotes sustained pulmonary vasoconstriction in hypoxia.细胞色素 P450 环氧合酶衍生的 5,6-环氧二十碳三烯酸在常氧下使肺动脉舒张，但在低氧下促进持续的肺血管收缩。
Acta Physiol (Oxf). 2020 Sep;230(1):e13521. doi: 10.1111/apha.13521. Epub 2020 Jun 22.
6
Recent Research Advances in Renin-Angiotensin-Aldosterone System Receptors.肾素-血管紧张素-醛固酮系统受体的最新研究进展。
Curr Hypertens Rep. 2020 Feb 29;22(3):22. doi: 10.1007/s11906-020-1028-6.
7
Mechanisms of Cardiovascular Toxicity of BCR-ABL1 Tyrosine Kinase Inhibitors in Chronic Myelogenous Leukemia.BCR-ABL1 酪氨酸激酶抑制剂在慢性髓性白血病中心血管毒性的作用机制。
Curr Hematol Malig Rep. 2020 Feb;15(1):20-30. doi: 10.1007/s11899-020-00560-x.
8
Tyrosine Kinase Inhibitors in Leukemia and Cardiovascular Events: From Mechanism to Patient Care.酪氨酸激酶抑制剂在白血病和心血管事件中的作用：从机制到患者护理。
Arterioscler Thromb Vasc Biol. 2020 Feb;40(2):301-308. doi: 10.1161/ATVBAHA.119.313353. Epub 2019 Dec 26.
9
Regulation of YAP by Mammalian Target of Rapamycin Complex 1 in Endothelial Cells Controls Blood Pressure Through COX-2/mPGES-1/PGE Cascade.雷帕霉素靶蛋白复合物 1 对内皮细胞中 YAP 的调节通过 COX-2/mPGES-1/PGE 级联反应控制血压。
Hypertension. 2019 Oct;74(4):936-946. doi: 10.1161/HYPERTENSIONAHA.119.12834. Epub 2019 Aug 5.
10
sEH Inhibitor Tppu Ameliorates Cecal Ligation and Puncture-Induced Sepsis by Regulating Macrophage Functions.sEH 抑制剂 Tppu 通过调节巨噬细胞功能改善盲肠结扎穿刺诱导的脓毒症。
Shock. 2020 Jun;53(6):761-771. doi: 10.1097/SHK.0000000000001408.